Community Health Centers' Response to COVID-19 and Serving the Community: This Feeling of Never Being Enough and Never Doing Enough. Publication Year 2025 Hurtado C, Harrison JD, Ivey SL, Fleming MD, Potter MB, Lewis G, Khandelwal S, Nguyen T, Ofman D, Moheno L, Carbajal M, Echaveste M, Osborne K, Bossier G, Palmer NR Disparities Among Asian and Black Patients with Cancer in Receipt of Palliative Care in a Single Urban Academic Cancer Center. Publication Year 2025 Nattinger C, Nouri S, O'Riordan DL, Rabow MW Adjustable continence therapy for men (ProACTTM): systematic review and compendium of adverse events. Publication Year 2025 Fernandez AM, Patel HV, Li KD, Balakrishnan AS, Buie J, Ghaffar U, Hakam N, Breyer BN Rural-Urban Differences and Socioeconomic Disparities in Long-Term Urinary Adverse Events Following Prostate Cancer Treatment. Publication Year 2025 Carlisle MN, Li KD, Jarosek SL, Faris AR, Patel HV, Washington SL, Breyer BN Rural-Urban Differences and Socioeconomic Disparities in Long-Term Urinary Adverse Events Following Prostate Cancer Treatment. Publication Year 2025 Carlisle MN, Li KD, Jarosek SL, Faris AR, Patel HV, Washington SL, Breyer BN Comorbid urolithiasis significantly increases utilization across healthcare settings for individuals with spina bifida. Publication Year 2025 VanderVeer-Harris N, Li Y, Fernandez A, Goldberg D, Allen IE, Kyaw TS, Hampson LA, Copp HL Comorbid urolithiasis significantly increases utilization across healthcare settings for individuals with spina bifida. Publication Year 2025 VanderVeer-Harris N, Li Y, Fernandez A, Goldberg D, Allen IE, Kyaw TS, Hampson LA, Copp HL Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data. Publication Year 2025 Li KD, Carlisle MN, Jarosek S, Patel HV, Faris A, Elliott SP, Cooperberg MR, Carroll PR, Breyer BN Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer. Publication Year 2025 St-Laurent MP, Singh P, McConkey DJ, Lucia MS, Koshkin VS, Stratton KL, Bivalacqua TJ, Kassouf W, Porten SP, Bangs R, Plets M, Thompson IM, Meeks JJ, Caruso VM, Ward CT, Mazzarella BC, Phillips KG, Bicocca VT, Levin TG, Lerner SP, Black PC Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data. Publication Year 2025 Li KD, Carlisle MN, Jarosek S, Patel HV, Faris A, Elliott SP, Cooperberg MR, Carroll PR, Breyer BN « First < Prev … 29 Current page30 31 … Next > Last » Print this page
Community Health Centers' Response to COVID-19 and Serving the Community: This Feeling of Never Being Enough and Never Doing Enough. Publication Year 2025 Hurtado C, Harrison JD, Ivey SL, Fleming MD, Potter MB, Lewis G, Khandelwal S, Nguyen T, Ofman D, Moheno L, Carbajal M, Echaveste M, Osborne K, Bossier G, Palmer NR
Disparities Among Asian and Black Patients with Cancer in Receipt of Palliative Care in a Single Urban Academic Cancer Center. Publication Year 2025 Nattinger C, Nouri S, O'Riordan DL, Rabow MW
Adjustable continence therapy for men (ProACTTM): systematic review and compendium of adverse events. Publication Year 2025 Fernandez AM, Patel HV, Li KD, Balakrishnan AS, Buie J, Ghaffar U, Hakam N, Breyer BN
Rural-Urban Differences and Socioeconomic Disparities in Long-Term Urinary Adverse Events Following Prostate Cancer Treatment. Publication Year 2025 Carlisle MN, Li KD, Jarosek SL, Faris AR, Patel HV, Washington SL, Breyer BN
Rural-Urban Differences and Socioeconomic Disparities in Long-Term Urinary Adverse Events Following Prostate Cancer Treatment. Publication Year 2025 Carlisle MN, Li KD, Jarosek SL, Faris AR, Patel HV, Washington SL, Breyer BN
Comorbid urolithiasis significantly increases utilization across healthcare settings for individuals with spina bifida. Publication Year 2025 VanderVeer-Harris N, Li Y, Fernandez A, Goldberg D, Allen IE, Kyaw TS, Hampson LA, Copp HL
Comorbid urolithiasis significantly increases utilization across healthcare settings for individuals with spina bifida. Publication Year 2025 VanderVeer-Harris N, Li Y, Fernandez A, Goldberg D, Allen IE, Kyaw TS, Hampson LA, Copp HL
Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data. Publication Year 2025 Li KD, Carlisle MN, Jarosek S, Patel HV, Faris A, Elliott SP, Cooperberg MR, Carroll PR, Breyer BN
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer. Publication Year 2025 St-Laurent MP, Singh P, McConkey DJ, Lucia MS, Koshkin VS, Stratton KL, Bivalacqua TJ, Kassouf W, Porten SP, Bangs R, Plets M, Thompson IM, Meeks JJ, Caruso VM, Ward CT, Mazzarella BC, Phillips KG, Bicocca VT, Levin TG, Lerner SP, Black PC
Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data. Publication Year 2025 Li KD, Carlisle MN, Jarosek S, Patel HV, Faris A, Elliott SP, Cooperberg MR, Carroll PR, Breyer BN